G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 99 filers reported holding G1 THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26 | -42.2% | 17,755 | 0.0% | 0.00% | – |
| Q2 2023 | $45 | -6.2% | 17,755 | 0.0% | 0.00% | – |
| Q1 2023 | $48 | -81.3% | 17,755 | -62.5% | 0.00% | – |
| Q4 2022 | $257 | -100.0% | 47,394 | -0.8% | 0.00% | – |
| Q3 2022 | $597,000 | +153.0% | 47,765 | 0.0% | 0.00% | – |
| Q2 2022 | $236,000 | -82.3% | 47,765 | -72.7% | 0.00% | – |
| Q1 2022 | $1,332,000 | -84.4% | 175,225 | -79.0% | 0.00% | -100.0% |
| Q4 2021 | $8,519,000 | -22.9% | 834,427 | +1.3% | 0.00% | 0.0% |
| Q3 2021 | $11,055,000 | -39.1% | 823,742 | -0.5% | 0.00% | -50.0% |
| Q2 2021 | $18,157,000 | -52.8% | 827,589 | -48.2% | 0.00% | -50.0% |
| Q1 2021 | $38,468,000 | +37.9% | 1,598,848 | +3.1% | 0.00% | +33.3% |
| Q4 2020 | $27,901,000 | +61.6% | 1,550,910 | +3.7% | 0.00% | +50.0% |
| Q3 2020 | $17,267,000 | -54.9% | 1,495,019 | -5.2% | 0.00% | -60.0% |
| Q2 2020 | $38,263,000 | +132.8% | 1,577,196 | +5.7% | 0.01% | +66.7% |
| Q1 2020 | $16,436,000 | -65.5% | 1,491,444 | -17.2% | 0.00% | -50.0% |
| Q4 2019 | $47,579,000 | +14.7% | 1,800,184 | -1.2% | 0.01% | 0.0% |
| Q3 2019 | $41,496,000 | -5.0% | 1,821,595 | +27.9% | 0.01% | 0.0% |
| Q2 2019 | $43,679,000 | +76.6% | 1,424,609 | -4.4% | 0.01% | +50.0% |
| Q1 2019 | $24,737,000 | -24.0% | 1,490,167 | -12.3% | 0.00% | -33.3% |
| Q4 2018 | $32,540,000 | -67.9% | 1,699,199 | -12.5% | 0.01% | -60.0% |
| Q3 2018 | $101,516,000 | +67.7% | 1,941,412 | +39.3% | 0.02% | +66.7% |
| Q2 2018 | $60,548,000 | +46.5% | 1,393,198 | +24.9% | 0.01% | +28.6% |
| Q1 2018 | $41,321,000 | – | 1,115,268 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 994,287 | $19,041,000 | 1.55% |
| HHLR ADVISORS, LTD. | 949,431 | $18,182,000 | 0.75% |
| BB BIOTECH AG | 671,925 | $12,867,000 | 0.41% |
| Rhenman & Partners Asset Management AB | 172,820 | $3,310,000 | 0.38% |
| Birchview Capital, LP | 15,000 | $287,000 | 0.27% |
| Rock Springs Capital Management LP | 100,000 | $1,915,000 | 0.09% |
| SECOR Capital Advisors, LP | 32,591 | $624,000 | 0.08% |
| MARSHALL WACE, LLP | 386,510 | $7,402,000 | 0.08% |
| SIGNATUREFD, LLC | 37,942 | $727,000 | 0.07% |
| A.R.T. Advisors, LLC | 38,125 | $730,000 | 0.05% |